A2457012
CP-673451 , ≥98% , 343787-29-1
Synonym(s):
1-[2-[5-(2-Methoxyethoxy)-1H-benzimidazol-1-yl]-8-quinolinyl]-4-piperidinamine;1-[2-[5-(2-Methoxyethoxy)benzimidazol-1-yl]quinolin-8-yl]piperidin-4-ylamine
| Pack Size | Price | Stock | Quantity |
| 1MG | RMB183.20 | In Stock |
|
| 5MG | RMB639.20 | In Stock |
|
| 10mg | RMB1151.20 | In Stock |
|
| 25MG | RMB2239.20 | In Stock |
|
| 50mg | RMB3431.20 | In Stock |
|
| 100MG | RMB4799.20 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Boiling point: | 656.3±65.0 °C(Predicted) |
| Density | 1.32 |
| storage temp. | Store at -20°C |
| solubility | insoluble in H2O; ≥2.39 mg/mL in EtOH with gentle warming and ultrasonic; ≥20.9 mg/mL in DMSO |
| form | Powder |
| pka | 9.84±0.20(Predicted) |
| color | White to off-white |
Description and Uses
1-[2-[5-(2-Methoxyethoxy)benzimidazol-1-yl]quinolin-8-yl]piperidin-4-ylamine exhibits antiangiogenic and antitumor properties. It is an inhibitor of platelet-derived growth factor receptor β (PDGFR- β).
Safety
| Symbol(GHS) |  GHS07 |
| Signal word | Warning |
| Hazard statements | H302-H315-H319-H335 |
| Precautionary statements | P261-P305+P351+P338 |
